Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -8.34x is 99% above its 4-year average of -560.68x, near the high end of its 4-year range (-851.25x–-8.34x).
As of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -8.34x.
INTEREST COVERAGE RATIO
-8.34x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
-560.68x
INTEREST COVERAGE RATIO AVG 10Y
-560.68x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+98.51%
CURRENT VS 10Y AVG
+98.51%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-30.81%
vs the sector median at left
Corvus Pharmaceuticals, Inc.
Market Cap
$887.99M
Interest Coverage Ratio
-8.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
-560.68x
Market Cap
$887.50M
Interest Coverage Ratio
2.21x
TTM Avg
2.21x
3Y Avg
2.21x
5Y Avg
5.08x
Market Cap
$884.97M
Interest Coverage Ratio
-278.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$870.81M
Interest Coverage Ratio
-9479.76x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$914.73M
Interest Coverage Ratio
N/A
TTM Avg
204.36x
3Y Avg
142.82x
5Y Avg
142.82x
Market Cap
$857.16M
Interest Coverage Ratio
-5.18x
TTM Avg
6.05x
3Y Avg
536.48x
5Y Avg
359.36x
Market Cap
$921.06M
Interest Coverage Ratio
-33.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | $887.99M | -8.34x | N/A | N/A | -560.68x |
| Bioventus Inc. (BVS)vs › | $887.50M | 2.21x | 2.21x | 2.21x | 5.08x |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | -278.88x | N/A | N/A | N/A |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | -9479.76x | N/A | N/A | N/A |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | -4.23x | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $914.73M | N/A | 204.36x | 142.82x | 142.82x |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | -5.18x | 6.05x | 536.48x | 359.36x |
| Alumis Inc. (ALMS)vs › | $855.38M | N/A | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $921.06M | -33.78x | N/A | N/A | N/A |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 17.14x | 10.10x | 10.10x | 10.10x |
Interest Coverage
-8.3x
Debt/Equity
0.00
Current Ratio
16.16
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -8.34x |
| 2021-12-31 | -851.25x |
| 2021-09-30 | -822.45x |
| 2015-09-30 | -100.65x |
